• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NOVO NORDISK A/S, MEDICAL SYSTEMS NOVOPEN ECHO; INSULIN DELIVERY DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NOVO NORDISK A/S, MEDICAL SYSTEMS NOVOPEN ECHO; INSULIN DELIVERY DEVICE Back to Search Results
Model Number N/A
Device Problems Crack (1135); Improper Flow or Infusion (2954)
Patient Problem Hyperglycemia (1905)
Event Type  Injury  
Event Description
Hyperglycaemia [hyperglycaemia].Small crack in the cartridge holder that made the piston not work properly [device breakage].The piston not work properly, thus causing the possible loss of doses.[drug delivery system malfunction].High levels of ketone bodies [blood ketone body increased].This serious spontaneous case from (b)(6) was reported by a pharmacist as "hyperglycaemia(hyperglycaemia)" with an unspecified onset date, "small crack in the cartridge holder that made the piston not work properly(device breakage)" with an unspecified onset date, "the piston not work properly, thus causing the possible loss of doses.(drug delivery system malfunction)" with an unspecified onset date, "high levels of ketone bodies(blood ketone body increased)" with an unspecified onset date, and concerned a (b)(6) male patient who was treated with novopen echo (insulin delivery device) from unknown start date for "device therapy", patient's height, weight and body mass index not reported.Medical history was not provided.On an unknown date, the patient started treatment with novopen echo.On an unknown date, the patient experienced hyperglycaemia , exceeding 300 and even 400 mg/dl (treatment details not specified) because the patient noticed a small crack in the cartridge holder that made the piston not work properly, thus causing the possible loss of doses after the pen was disassembled on (b)(6) 2021 the patient was hospitalized due to several days of hyperglycaemia.On (b)(6) 2021, patient discharged from the hospital).Patient also had high levels of ketone bodies (dates not specified).Batch number of novopen echo was dv40072 (non-valid) action taken to novopen echo was not reported.The outcome for the event "hyperglycaemia(hyperglycaemia)" was not reported.The outcome for the event "small crack in the cartridge holder that made the piston not work properly(device breakage)" was not reported.The outcome for the event "the piston not work properly, thus causing the possible loss of doses.(drug delivery system malfunction)" was not reported.The outcome for the event "high levels of ketone bodies(blood ketone body increased)" was not reported.Preliminary manufacturer's comment: 26-jul-2021: the suspected device novopen echo has not been returned to novo nordisk for investigation.No conclusion is reached.
 
Event Description
Case description: this serious spontaneous case from spain was reported by a pharmacist as "hyperglycaemia(hyperglycaemia)" beginning on (b)(6) 2021, "small crack in the cartridge holder that made the piston not work properly(device breakage)" with an unspecified onset date, "the piston not work properly, thus causing the possible loss of doses.(drug delivery system malfunction)" with an unspecified onset date, "high levels of ketone bodies(blood ketone body increased)" with an unspecified onset date, and concerned a 15 years old male patient who was treated with novopen echo (insulin delivery device) from unknown start date for "device therapy", on (b)(6) 2021, the patient experienced hyperglycaemia and was hospitalized due to several days.The blood glucose levels were exceeding 300 and even 400 mg/dl (treatment details not specified) because the patient noticed a small crack in the cartridge holder that made the piston not work properly, thus causing the possible loss of doses after the pen was disassembled the force needed to inject was normal.The patient use the dialing clicks to estimate the dose of the product and attach the needle to the pen in a 180 degree angle (straight on).A new pen was received by the patient.On (b)(6) 2021 the outcome for the event "hyperglycaemia(hyperglycaemia)" was recovered.The outcome for the event "small crack in the cartridge holder that made the piston not work properly(device breakage)" was not reported.The outcome for the event "the piston not work properly, thus causing the possible loss of doses.(drug delivery system malfunction)" was not reported.The outcome for the event "high levels of ketone bodies(blood ketone body increased)" was recovered.Investigation result: novopen echo - batch dv40072.A visual examination of the returned product was performed.The cartridge holder was damaged in its connection to the mechanical part of the pen.It was not possible to attach the cartridge holder correctly and the device could not function with a needle and a cartridge attached.This would also affect the plunger.The dose accuracy might be affected.The fault was caused by accidental damage during use of the device.The electronic register was checked.The results showed that the pen had been in use for 5 years.The pen had reached its end of life.Visual examination and functional testing were performed.The memory display showed "end".Mechanical functions which could be tested without the cartridge holder attached to the pen were found to be normal.Since last submission case has been updated with the following: -investigation result updated.-device tab, eu/ca tab and device addendum tab updated.-narrative updated accordingly.Final manufacturer's comment: 27-aug-2021: the suspected device novopen echo has been returned to novo nordisk for investigation.It was found that cartridge holder was damaged due to accidental damage during the use of the device.It is not possible to attach the cartridge holder correctly and the device cannot function with a needle and a cartridge attached.The dose accuracy may be affected.If the user does not detect the fault on the cartridge holder there is a risk that the patient will only receive a partial or no dose at all and could experience hyperglycemic related events.It thus cannot be excluded that the damaged cartridge holder could have contributed to the experienced hyperglycaemia.H3 continued: evaluation summary: novopen echo - batch dv40072.A visual examination of the returned product was performed.The cartridge holder was damaged in its connection to the mechanical part of the pen.It was not possible to attach the cartridge holder correctly and the device could not function with a needle and a cartridge attached.This would also affect the plunger.The dose accuracy might be affected.The fault was caused by accidental damage during use of the device.The electronic register was checked.The results showed that the pen had been in use for 5 years.The pen had reached its end of life.Visual examination and functional testing were performed.The memory display showed "end".Mechanical functions which could be tested without the cartridge holder attached to the pen were found to be normal.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NOVOPEN ECHO
Type of Device
INSULIN DELIVERY DEVICE
Manufacturer (Section D)
NOVO NORDISK A/S, MEDICAL SYSTEMS
hilleroed,,
DA 
MDR Report Key12273174
MDR Text Key264945666
Report Number9681821-2021-00042
Device Sequence Number1
Product Code FMF
Combination Product (y/n)N
PMA/PMN Number
K123766
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 07/09/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/04/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date03/31/2016
Device Model NumberN/A
Device Lot NumberDV40072
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/29/2021
Date Manufacturer Received08/16/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
Patient Age15 YR
-
-